I
view mainly as dumb luck the way I dodged the magic bullet of opioid dependence during my treatment for throat cancer 6 years ago. My doctors forewarned that radiation and chemotherapy together wreak havoc on throat tissues. I was sent home with a quart of pink liquid and a recommendation to use it preventively, just before I felt that pain might be coming on. They guaranteed I would need it. No one mentioned any other options for pain management.
I never needed the painkillers. One factor may be a cautionary view toward medication passed down in my natal family. Another may have been my use of multiple self-care and integrative methods and practitioners before, during, and after treatment. A friend who underwent a similar throat cancer treatment protocol who also took advantage of multiple integrative therapies had such pain that she needed ultimately to find her way to her new normal through a foggy tunnel of opioid dependency. My family joked that the grace that kept me from opioids could be chalked up to gross insensitivity.
Bullet-dodging in my episode of pain treatment did not end there. A year later, a neighbor shared that he was in horrible chronic joint pain linked to an athletic overuse injury. I mentioned the painkiller in the house. He thanked me and left with the bottle. He returned within hours, thrusting the quart back at me. He explained that he had a past addiction to pain medications. The proximity of excess leftover prescription opioids nearly pushed him off the wagon. Another magic bullet dodged.
Versions of this experience are reflected in the lives of tens of millions of individuals since 2000 when what was then called the Joint Commission on Accreditation of Healthcare Organizations passed pain standards for healthcare organizations in the United States. The standard focused on ensuring that pain was treated. Accreditation's quasi-police power pushed healthcare workers to err on the side of prescribing. Opioids and other painkillers became readily available. Dosing also tended toward the high end. Unused medications frequently ended up with unintended users. Pain treatment was characterized by active promotion, overprescription, unintended use, addiction, and no reference to options that might limit or obviate the need for painkillers.
In recent months, a pattern in pain policy is emerging that may help resolve the opioid epidemic in the United States that was triggered by the post-2000 standard. Nonpharmacological approaches and practitioners and the activities of individuals and consortia linked to the integrative health and medicine fields figure heavily in this shifting policy landscape. The remainder of this column reviews this activity over the past half-decade that is paving the way toward a wholesystem, inclusive pain standard.
Without doubt, the most significant motivations for change are the dimensions of mortality and morbidity of the epidemic itself. Key data are captured in an October 2014 policy brief called "Never Only Opioids: The Imperative for Early Integration of NonPharmacological Approaches and Practitioners in the Treatment of Patients with Pain." The 8-page paper notes that deaths associated with prescription opioids soared 400% in women and 265% in men in a decade; painkillers contribute to more than 17 000 deaths annually; NSAIDs and acetaminophen send another 80 000 each year to emergency rooms; problems are worse among members of the military; and painkillers of all kinds have become problematic street drugs, with multiple negative impacts on families and communities. 1 This policy document and the associated recommendations were published through the Pain Action Alliance to Implement a National Strategy (PAINS), a national initiative involving more than 40 mainly pharmacy-oriented pain organizations. TOwARD A cONSERVATIVE, whOLE-SYSTEm TREATmENT STANDARD FOR PAIN MAOM, recommended an integrated, interdisciplinary approach. The committee noted, for instance, that "treatments can include medications, surgery, behavioral interventions, psychological counseling, rehabilitative and physical therapy, and complementary and alternative therapies." 2 An analysis I wrote in the Integrator Blog News and Reports found that the latter set of treatments-"complementary and alternative therapies"-merited mention in 15 segments of the IOM report. 3 However, the itemization as last, as above, reflects an overall limited integration of these approaches with the content and recommendations in the remainder of the IOM report. This dead-last positioning mirrored that of nonpharmacological approaches in a 2007 low back pain guideline from the American College of Physicians and the American Pain Society. Complementary and alternative medicine therapies made the list but as seventh among seven options for consideration. Even the Joint Commission's 2000 pain standard mentioned that some nonpharmacological approaches had evidence of value. Yet the message there, as in the subsequent documents, is that these approaches are not first-tier options. They are more of a last resort, eg, If all else fails, try acupuncture.
A more proactive approach toward complementary and alternative approaches and practitioners was simultaneously brewing in pain treatment practices in the US military. Like other early adopters of complementary and alternative medicine approaches such as entertainers and athletes, the military is performancebased and outcomes-driven. Soldiers, from pilots to ground troops, can be dangerously impaired via adverse medication effects. "Never Only Opioids" describes policy changes in the Affordable Care Act that indirectly support an affirmative embrace of non-pharmacologic options, even as the Act's funding of the 2011 IOM Blueprint directly engaged this shift in pain practice. The PAINS policy brief notes multiple components of the effort to shift the medical industry to a values-based system that supports a whole-systems approach: interprofessionalism, team care, patient-centered medical homes, accountable care, and even cost savings. Cited, for instance, is the IOM Blueprint's reference to a study of insured users of covered practitioners of licensed complementary and alternative medicine that found that users "had lower average expenditures that non-users" and that, notably for a system increasingly focusing on high-utilizers, "people who had the heaviest disease burdens accounted for the highest level of savings, an average of $1420." 4 The PAINS policy brief generated 13 recommendations for research funders, healthcare delivery, federal agencies, and health professions educators. Among these were increasing funding for studies that seek to limit use of painkillers through integrative
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means; bringing licensed integrative practitioners onto pain teams; requiring health professional education to include experiential programs in mind-body and self-care approaches that "elevate the idea of neuroplasticity (change the brain, change the pain) of the brain"; and promoting effort in the military toward "technology transfer" of successful programs for the civilian population. 5 The effort to bring formerly last-resort therapies and practitioners into early integration that is advocated in the "Never Only Opioids" brief received powerful policy support on November 12, 2014. The Joint Commission, responding to a petition from integrative health and medicine interests, issued a clarification of its accreditation pain standard that significantly elevated the importance of nonpharmacological approaches. 6 Acupuncturist Arya Nielsen led a campaign to urge that the Joint Commission reconsider its 2000 pain standard. The effort was ultimately backed by the medical system in which she works, Mount Sinai Beth Israel, and 20 members of CAHCIM. The Joint Commission's clarification essentially placed nonpharmacological and pharmacological approaches on par. In addition, the clarified standard underscored that personnel in accredited inpatient and outpatient centers must ensure that potential adverse effects of pharmacological strategies are considered alongside positive values actively taken into consideration in decision making.
These actions bring no guarantee that a patient entering a hospital or outpatient facility with throat cancer, as I did in 2009, or any other pain-related condition will find nonpharmacological options on the menu. The clarified pain standard doesn't, for instance, have the most powerful of the Joint Commission's police power backing it. Yet at the same time, this series of actions relative to pain treatment in the last half decade in both civilian and military communities is clearly moving pain treatment toward an inclusive, conservative, whole-person standard.
